These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8092142)

  • 41. Post-transplant induction of donor-type anti-RhD antibodies production shortly followed by complete hemolysis of recipient-type erythrocytes in RhD-mismatched allogeneic bone marrow recipient.
    Markiewicz M; Wojnar J; Giebel S; Wieczorkiewicz A; Wylezoł I; Hołowiecki J
    Bone Marrow Transplant; 2006 Feb; 37(4):433-4. PubMed ID: 16400335
    [No Abstract]   [Full Text] [Related]  

  • 42. [Acute myelogenous leukemia with mediastinal and subcutaneous emphysema following chronic GVHD after allogeneic bone marrow transplantation].
    Doki N; Irisawa H; Saito Y; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2005 Sep; 46(9):1038-43. PubMed ID: 16440761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Translocation (7;9)(q22;q34) in therapy-related myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloblastic leukemia.
    Yamamoto K; Yakushijin K; Kawamori Y; Minagawa K; Katayama Y; Matsui T
    Cancer Genet Cytogenet; 2007 Jul; 176(1):61-6. PubMed ID: 17574966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transient ring sideroblastosis in an allogeneic human bone marrow graft [proceedings].
    Rozman C; Granena A; Woessner S; Brugués R
    Pathol Biol (Paris); 1978 Jan; 26(1):46. PubMed ID: 358086
    [No Abstract]   [Full Text] [Related]  

  • 45. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
    Wong R; Shahjahan M; Wang X; Thall PF; De Lima M; Khouri I; Gajewski J; Alamo J; Couriel D; Andersson BS; Donato M; Hosing C; Komanduri K; Anderlini P; Molldrem J; Ueno NT; Estey E; Ippoliti C; Champlin R; Giralt S
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):108-14. PubMed ID: 15682071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recombinant human G-CSF combined regimen for allogeneic BMT in myeloid leukemias].
    Takahashi S
    Rinsho Ketsueki; 1997 Jun; 38(6):489-95. PubMed ID: 9248324
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polyvisceral arteritis in chronic graft-versus-host disease: antiphospholipid-negative thrombotic syndrome mimicking polyarteritis nodosa.
    Ysebaert L; Deconinck E; Larosa F; Caillot D; Tiberghien P; Casasnovas RO; Cahn JY
    Bone Marrow Transplant; 2002 May; 29(10):873-4. PubMed ID: 12058239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
    Bibawi S; Abi-Said D; Fayad L; Anderlini P; Ueno NT; Mehra R; Khouri I; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Andreeff M; Andersson BS; Estey EH; Champlin R; Przepiorka D
    Am J Hematol; 2001 Aug; 67(4):227-33. PubMed ID: 11443634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bone marrow transplantation in the treatment of acute leukemias].
    Moiseev SI; Ganapiev AA; Abdulkadyrov KM
    Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome.
    Fung HC; Stein A; Slovak Ml; O'donnell MR; Snyder DS; Cohen S; Smith D; Krishnan A; Spielberger R; Bhatia R; Bhatia S; Falk P; Molina A; Nademanee A; Parker P; Rodriguez R; Rosenthal J; Sweetman R; Kogut N; Sahebi F; Popplewell L; Vora N; Somlo G; Margolin K; Chow W; Smith E; Forman SJ
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):766-71. PubMed ID: 14677116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Malignant fibrous histiocytoma secondary to allogeneic bone marrow transplantation.
    Iori AP; Arcese W; Pinto RM; Favre C; Macchia P
    Bone Marrow Transplant; 1994 Sep; 14(3):492. PubMed ID: 7994282
    [No Abstract]   [Full Text] [Related]  

  • 53. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature.
    Mackey JR; Desai S; Larratt L; Cwik V; Nabholtz JM
    Bone Marrow Transplant; 1997 May; 19(9):939-42. PubMed ID: 9156270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation.
    Békássy AN; Hermans J; Gorin NC; Gratwohl A
    Bone Marrow Transplant; 1996 May; 17(5):801-8. PubMed ID: 8733701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide.
    Avalos BR; Klein JL; Kapoor N; Copelan EA
    Bone Marrow Transplant; 1993 Dec; 12(6):655-8. PubMed ID: 8136749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.
    Michel G; Boulad F; Small TN; Black P; Heller G; Castro-Malaspina H; Childs BH; Gillio AP; Papadopoulos EB; Young JW; Kernan NA; O'Reilly RJ
    Bone Marrow Transplant; 1997 Jul; 20(2):107-12. PubMed ID: 9244412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation.
    Baron FA; Hermanne JP; Dowlati A; Weber T; Thiry A; Fassotte MF; Fillet G; Beguin Y
    Bone Marrow Transplant; 1998 May; 21(9):951-4. PubMed ID: 9613791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial.
    Watson M; Buck G; Wheatley K; Homewood JR; Goldstone AH; Rees JK; Burnett AK;
    Eur J Cancer; 2004 May; 40(7):971-8. PubMed ID: 15093571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.